We are live on
!
Find out more
QC
Quantessence Capital Portfolio holdings
AUM
$20.5M
1-Year Est. Return
71.02%
This Fund
S&P 500
This Quarter
Est. Return
+20.04%
1 Year Est. Return
+71.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$316M
AUM Growth
-$23.5M
(-6.9%)
Cap. Flow
-$48.7M
Cap. Flow
% of AUM
-15.41%
Top 10 Holdings %
Top 10 Hldgs %
29.72%
Holding
324
New
143
Increased
13
Reduced
17
Closed
151
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WNS
WNS Holdings
WNS
|
+$24.5M |
| 2 |
VRNA
Verona Pharma
VRNA
|
+$11.5M |
| 3 |
Meta Platforms (Facebook)
META
|
+$8.22M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$6.46M |
| 5 |
ALE
Allete
ALE
|
+$6.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AZEK
The AZEK Co
AZEK
|
+$63.6M |
| 2 |
RDFN
Redfin
RDFN
|
+$40.6M |
| 3 |
Sprouts Farmers Market
SFM
|
+$7.51M |
| 4 |
Carpenter Technology
CRS
|
+$6.74M |
| 5 |
Rocket Lab Corp
RKLB
|
+$6.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.51% |
| 2 | Healthcare | 14.73% |
| 3 | Communication Services | 12.99% |
| 4 | Materials | 10.95% |
| 5 | Industrials | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PSKY
151
Paramount Skydance Corp
PSKY
$9.67B
| $234K | 0.07% |
+12,364
| New | +$196K |
|
152
Expeditors International
EXPD
$23.2B
| $231K | 0.07% |
+1,885
| New | +$224K |
|
|
CVSA
153
Covista Inc
CVSA
$3.94B
| $229K | 0.07% |
+1,483
| New | +$190K |
|
|
LBRX
154
LB Pharmaceuticals
LBRX
$895M
| $225K | 0.07% |
+14,225
| New | +$226K |
|
155
Middlesex Water
MSEX
$1.05B
| $221K | 0.07% |
+4,086
| New | +$219K |
|
156
SGHC Ltd
SGHC
$7.91B
| $219K | 0.07% |
+16,621
| New | +$196K |
|
157
JB Hunt Transport Services
JBHT
$27.3B
| $218K | 0.07% |
+1,625
| New | +$234K |
|
158
Columbia Sportswear
COLM
$3.16B
| $215K | 0.07% |
+4,102
| New | +$231K |
|
159
Jazz Pharmaceuticals
JAZZ
$15.4B
| $212K | 0.07% |
+1,609
| New | +$193K |
|
160
InterDigital
IDCC
$6.74B
| $209K | 0.07% |
+604
| New | +$164K |
|
|
UNIT
161
Uniti Group
UNIT
$2.7B
| $203K | 0.06% |
+33,130
| New | +$198K |
|
162
Core Laboratories
CLB
$518M
| $192K | 0.06% |
+15,560
| New | +$182K |
|
163
Viatris
VTRS
$19.8B
| $177K | 0.06% |
17,858
-170,011
| -90% | -$1.65M |
|
164
Xencor
XNCR
$1.4B
| $154K | 0.05% |
+13,094
| New | +$114K |
|
165
American Airlines Group
AAL
$10.1B
| $145K | 0.05% |
+12,873
| New | +$159K |
|
166
Myriad Genetics
MYGN
$559M
| $138K | 0.04% |
+19,113
| New | +$113K |
|
|
DVAX
167
DELISTED
Dynavax Technologies
DVAX
| $123K | 0.04% |
12,338
-5,848
| -32% | -$60.9K |
|
168
Avanos Medical
AVNS
$1.17B
| $116K | 0.04% |
+10,000
| New | +$117K |
|
169
American Express Global Business Travel
GBTG
$4.91B
| $111K | 0.04% |
13,683
-5,302
| -28% | -$39.3K |
|
170
Sabre
SABR
$680M
| $87.5K | 0.03% |
+47,821
| New | +$113K |
|
171
Compass Diversified
CODI
$755M
| $69.8K | 0.02% |
+10,546
| New | +$72.7K |
|
172
Krispy Kreme
DNUT
$552M
| $65.9K | 0.02% |
+17,022
| New | +$58.7K |
|
173
Maravai LifeSciences
MRVI
$1.04B
| $30.8K | 0.01% |
+10,727
| New | +$27.4K |
|
|
ACLX
174
DELISTED
Arcellx
ACLX
| – | – |
-4,750
| Closed | -$313K |
|
175
AES
AES
$10.6B
| – | – |
-95,615
| Closed | -$1.01M |
|
Similar funds
FS
BC
PMAM
LFA
HAM
DP
SPC
IW
Quantessence Capital's Q3 2025 Portfolio in Review
As of Q3 2025, Quantessence Capital held 324 positions worth $316M, down 6.9% from $340M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Quantessence Capital withdrew a net $48.7M in Q3 2025, closing 151 positions and reducing 17 holdings. Its most notable exit was The AZEK Co, an estimated $63.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 6.9% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Quantessence Capital opened a new position in WNS Holdings worth $25M.
- Quantessence Capital's largest Q3 2025 buy was WNS Holdings: 327,371 shares worth $25M.
- Quantessence Capital added most to VanEck Oil Services ETF in Q3 2025, an estimated $5.7M increase.
- Quantessence Capital's biggest Q3 2025 reduction was Insmed, cutting an estimated $5.83M.
- Quantessence Capital fully exited The AZEK Co in Q3 2025, selling an estimated $63.6M.
- Quantessence Capital's ten largest holdings make up 30% of its $316M portfolio in Q3 2025.
- Quantessence Capital opened 143 new positions and closed 151 in Q3 2025.
- Quantessence Capital's portfolio value fell 6.9% quarter-over-quarter to $316M.
Based on Quantessence Capital's 13F filing for Q3 2025, filed 14 Nov 2025.